EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Repeat cell-free DNA screening after initial false-positive results and term placental analysis for confined mosaicism: a prospective cohort study

Yvette C Raymond, Shavi Fernando, Melody Menezes, Ben W Mol, Tristan Hardy, Kara Levin, Emma Brown, Andrew McLennan, Daniel Lorber Rolnik

Archives of Gynecology and Obstetrics · 2025

DOI: 10.1007/s00404-025-08162-9 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Archives of Gynecology and Obstetrics, 2025. Verfasst von Yvette C Raymond und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Monash University, Clayton, Australia. Yvette.raymond@monash.edu. Hauptthemen laut MEDLINE: Cell-Free Nucleic Acids, Placenta, Mosaicism, Noninvasive Prenatal Testing. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council (NHMRC) Investigator grant, Norman Beischer Medical Research Foundation, Monash IVF Research, New Technologies, and Science Communication committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

False-positive prenatal cell-free DNA screening (cfDNA) results may arise from confined placental mosaicism (CPM). This cohort study examines the persistence of high-risk cfDNA in the third pregnancy trimester after exclusion of fetal involvement, and the concordance of these results with CPM in the postpartum placenta.

Methods

Pregnant individuals receiving a false-positive primary cfDNA result were recruited from Monash Health and Monash Ultrasound for Women in Melbourne, Australia, between August 2023 and December 2024. Participants underwent genome-wide repeat cfDNA screening ( r -cfDNA) after 30 + 0 weeks’ gestation. Placental samples were collected and cytogenetically analysed postpartum.

Results

This cohort included 21 individuals, of which 33.3% (7/21) screened high-risk on r -cfDNA. There was no significant association between r -cfDNA and CPM in the postpartum placenta ( p = 0.397), as five (5/12, 41.7%) cases involving CPM were screened ‘low-risk’. Fetal-fraction was significantly lower (5.0% [IQR = 4.6–8.0%] vs. 9.0% [IQR = 7.0–13.5%], p = 0.025), and maternal BMI (Kg/m2) higher (29.0 [IQR = 25.7–31.2] vs. 23.3 [IQR = 22.0–24.9], p = 0.006), in false-positive cases not attributable to CPM detected by r -cfDNA or postpartum. High-risk r -cfDNA results were associated with smaller babies (median birthweight percentile = 12.3 [IQR = 4.4–21.7] vs. 31.9 [IQR = 21.5–55.5], p = 0.009), though the majority of outcomes were favorable.

Conclusion

High-risk r -cfDNA is not a sensitive predictor of CPM, though high mosaic ratios are associated with adverse obstetric outcomes. An alternative explanation for false-positive cfDNA besides CPM may be low fetal fraction, particularly in the context of high maternal BMI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell-Free Nucleic AcidsPlacentaMosaicismNoninvasive Prenatal TestingPrenatal DiagnosisHumansFemalePregnancyFalse Positive ReactionsAdultProspective Studies

Stichwörter der Autor:innen

Cell-free DNAConfined placental mosaicismNon-invasive prenatal testingPlacenta insufficiency

Substanzen

Cell-Free Nucleic Acids

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Monash University, Clayton, Australia. Yvette.raymond@monash.edu.
  • Department of Obstetrics and Gynecology, Monash University, Clayton, Australia.
  • Monash Women's, Monash Health, Clayton, Australia.
  • Monash Obstetrics, Clayton, Australia.
  • Victorian Clinical Genetic Services Ltd, Parkville, Australia.
  • Department of Pediatrics, The University of Melbourne, Melbourne, Australia.

Förderung

  • National Health and Medical Research Council (NHMRC) Investigator grant
  • Norman Beischer Medical Research Foundation
  • Monash IVF Research, New Technologies, and Science Communication committee
  • Monash University

Zitieren

APA

Raymond, Y. C., Fernando, S., Menezes, M., Mol, B. W., Hardy, T., Levin, K., Brown, E., McLennan, A., & Lorber Rolnik, D. (2025). Repeat cell-free DNA screening after initial false-positive results and term placental analysis for confined mosaicism: a prospective cohort study. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-025-08162-9

Vancouver

Raymond YC, Fernando S, Menezes M, Mol BW, Hardy T, Levin K, et al. Repeat cell-free DNA screening after initial false-positive results and term placental analysis for confined mosaicism: a prospective cohort study. Archives of Gynecology and Obstetrics. 2025. doi:10.1007/s00404-025-08162-9

BibTeX
@article{Raymond2025,
  author = {Raymond, Yvette C and Fernando, Shavi and Menezes, Melody and Mol, Ben W and Hardy, Tristan and Levin, Kara and Brown, Emma and McLennan, Andrew and Lorber Rolnik, Daniel},
  title = {Repeat cell-free DNA screening after initial false-positive results and term placental analysis for confined mosaicism: a prospective cohort study},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2025},
  doi = {10.1007/s00404-025-08162-9}
}
Kostenlos starten →